scispace - formally typeset
J

Joshua F. Yarrow

Researcher at Veterans Health Administration

Publications -  76
Citations -  1632

Joshua F. Yarrow is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Spinal cord injury & Testosterone (patch). The author has an hindex of 21, co-authored 71 publications receiving 1325 citations. Previous affiliations of Joshua F. Yarrow include United States Department of Veterans Affairs & University of Florida.

Papers
More filters
Journal ArticleDOI

Training augments resistance exercise induced elevation of circulating brain derived neurotrophic factor (BDNF).

TL;DR: This study is the first to demonstrate that resistance exercise induces a robust, yet transient, elevation of circulating BDNF and that progressive resistance training augments this response; perhaps demonstrating one mechanism through which exercise influences brain health.
Journal ArticleDOI

Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis

TL;DR: Differences in the degree to which serum DHT is elevated may underlie the varying CV risk by TRT administration route, as elevated serum dihydrotestosterone has been shown to be associated with CV risk in observational studies.
Journal ArticleDOI

Growth hormone responses to acute resistance exercise with vascular restriction in young and old men

TL;DR: The data suggest that while low- load RE with vascular restriction is as effective for inducing a GH response than traditionally-based high-load RE, there is a more potent response in young men.
Journal ArticleDOI

Tissue selectivity and potential clinical applications of trenbolone (17β-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity

TL;DR: The metabolism of 17beta-TBOH provides a basis for future research evaluating its safety and efficacy as a means of combating muscle and bone wasting conditions, obesity, and/or androgen insensitivity syndromes in humans, similar to that of other SARMs which are currently in development.